Skip to content

Menopause Society of Ireland – Patient Experience Survey (NCPE Submission)


Introduction
This anonymous survey is conducted by the Menopause Society of Ireland (MSI) to inform a patient submission to the National Centre for Pharmacoeconomics (NCPE) as part of a Health Technology Assessment (HTA).

  • Participation is voluntary
  • No identifying information will be collected.
  • Responses will be analysed in aggregate and may be quoted in anonymised form.
  • By proceeding, you confirm that you are aged 18 or over and consent to the use of your anonymised responses.
This survey asks about your experience with vasomotor symptoms (VMS) — including hot flushes, night sweats, and difficulties regulating body temperature — and your experience or expectations with Fezolinetant (Veoza™)

Data will be stored securely and accessed only by the Menopause Society of Ireland for the purpose described above

Please do not include any identifiable information.
Demographics
1.What is your age range?
VMS Symptoms
2.How bothersome are your VMS at present?
Not at all bothersome
Slightly
Moderately
Very
Extremely bothersome
3.Please describe how VMS have affected you (e.g., sleep, work, social life, emotional wellbeing, relationships)

Please do not include any identifiable information.
Current Treatments
4.How many other treatments or medications have you used for VMS (excluding Fezolinetant (Veoza™))?
None
1
2
3
More than 3
5.Describe your experience with current or past treatments (excluding Fezolinetant (Veoza™)) Please do not include any identifiable information.
Fezolinetant Use
6.Have you used fezolinetant to treat VMS?